NeoFipronis®
- Official registration and oversight
- GMP-standard manufacturing
- Batch testing and traceability
- Clear product information and consistency
DEDICATED TO CAT OWNERS.
To provide cat owners and veterinarians worldwide with clear, reliable information about NeoFipronis®, an officially registered 30 mg oral GS-441524 product related to FIP.
NeoFipronis® (Pronidesivir) is an officially registered 30 mg oral tablet product for cats. Each box includes scored tablets with product verification, batch traceability, and customer support information.
CAT HEALTH INFORMATION
Feline infectious peritonitis (FIP) is a serious disease associated with feline coronavirus. It may appear in different forms and may involve signs such as persistent fever, low appetite, weight loss, abdominal fluid, eye changes, or neurological abnormalities.
May involve fluid accumulation in the abdomen or chest.
May involve inflammatory changes in organs without obvious fluid buildup.
May involve eye-related changes such as cloudiness or inflammation.
May involve balance problems, tremors, seizures, or other neurological signs.
This section is provided for general educational purposes only and does not replace veterinary diagnosis, treatment, or medical advice.
SCIENTIFIC BACKGROUND
Research by Dr. Niels Pedersen and his team at UC Davis provided an important scientific foundation for GS-441524 and FIP. Built on this foundation, NeoFipronis® was developed as an oral GS-441524 (Pronidesivir) tablet and has been officially approved in Laos, aiming to provide cat owners with a reliable, traceable option to support cats affected by FIP.
PRODUCT NOTES
NeoFipronis® contains GS-441524, also known as Pronidesivir. Officially registered in Laos, it is a 30mg oral tablet product for cat owners learning about FIP.
A clear comparison of officially registered product information versus unverified alternatives.
TRUST & SUPPORT
Choosing NeoFipronis® means choosing the highest standard of regulatory compliance and pharmaceutical integrity in the FIP treatment market.
Authority: MAF
Reg. No.: ຢສ-F020326-0156
Oversight: DLF, Laos
Reg. Class: Non-prescription Vet Product
NeoFipronis® is designed to remove uncertainty from FIP treatment through legal registration, standardized manufacturing, and real-world clinical reliability.
Treat your cat without the legal and safety risks associated with unverified gray-market substances.
GMP-aligned production ensures consistent dosing, controlled quality, and reduced variability.
Many cats show noticeable improvement within days, depending on severity and response.
CUSTOMER SUPPORT
Our support team can help with product information, verification details, registration documents, and order-related questions.
Questions before ordering? Contact support for product details and verification help.
Submit your cat’s signs, weight, age, and case notes for a free FIP-related case review.
FAQ
Find answers about NeoFipronis®, product information, verification support, batch traceability, and customer support.
Free diagnostics, round-the-clock support, and 12 weeks of dedicated follow-up. No service fees—you only cover the cost of medication.
Commitment to a cure. If symptoms return, we cover all costs for treatment and professional guidance.
Contact support before making a decision.
NeoFipronis® is an officially registered 30 mg oral tablet product for cats, with verification support and batch traceability information.
Yes. NeoFipronis® contains GS-441524, also referred to as Pronidesivir.
Feline infectious peritonitis (FIP) is a serious disease associated with feline coronavirus. Diagnosis and health-related decisions should be made with a licensed veterinarian.
Yes. This page provides product-related information, verification details, registration information, and customer support.
Detailed product specifications and box options are available on the product details page.
Yes. Verification-related information and batch traceability support are available through the official website.
Yes. Customer support is available for product questions, verification details, and order-related assistance.
Yes. Please consult a licensed veterinarian for decisions related to your cat’s health.
We guide you from assessment to recovery. Every step is built around practical, evidence-based care—helping you navigate the 84-day treatment course and follow-up monitoring with confidence.
Share your cat’s symptoms, history, and test results.
We help identify FIP type, risk factors, and needed follow-up tests.
Weight-based dosing guidance and monitoring cadence (veterinary care first).
We help you begin safely with key precautions and daily routine tips.
Ongoing guidance throughout the 84-day course to reduce guesswork.
Log weight, appetite, energy, and key lab markers over time.
Supportive care suggestions (liver, kidney, probiotics) as needed—per your vet.
Post-treatment observation guidance and long-term wellness recommendations.
Reach out to our team today for reliable, science-based FIP treatment support.
Email: service@neofipronis.com
WhatsApp:+1 281 258-6794
loading